Investing in Exponential Growth Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : Investing in Exponential Growth

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: Paul H. Christiansen	10/17/2016 3:23:35 PM
	of 1084

The Recipe for the Perfect Robot Surgeon Intuitive Surgical’s da Vinci robot is a technical marvel. Nearly half a million operations were performed in the U.S. by surgeons controlling its large, precise arms last year. One in four U.S. hospitals has one or more of the machines, which perform the majority of robotic surgeries worldwide and are credited with making minimally invasive surgery commonplace. But when executives from Verb Surgical, a secretive joint venture between Alphabet and Johnson & Johnson, presented at the robotics industry conference RoboBusiness late last month, they made the da Vinci sound lame. A diagram from a patent filing shows a robot intended to be more nimble than those on the market. Intuitive’s machine, with an average selling price of $1.54 million, is too expensive and bulky, they grumbled. Pablo Garcia Kilroy, Verb’s vice president of research and technology, complained that while da Vinci is an impressive tool, it’s a dumb one that hasn’t widely transformed surgery. He said that while it enables surgeons to perform very delicate movements, it doesn’t assist with the cognitive skills that set the best surgeons apart. technologyreview.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next